Somersworth woman sentenced to between 10 to 20 years for selling fatal dose of fentanylBy PAUL FEELY
New Hampshire Union Leader
February 22. 2018 9:31AM
CONCORD — A Somersworth woman will serve 10 to 20 years in state prison after pleading guilty to selling a lethal amount of fentanyl to a Dover man who overdosed in 2016.
Kelly Flanagan, 39, also known as Kelly Silva, pleaded guilty Tuesday in Strafford County Superior Court to selling David Gross, 45, a deadly dose of drugs that caused his death on Oct. 4, 2016. She was arrested two days later after agreeing to sell opioids to someone working as an undercover agent. Flanagan was sentenced to 10 to 20 years in the New Hampshire State Prison, with 2 1/2 years of the minimum term suspended. Six months of the suspended portion of the sentence is conditional upon Flanagan successfully completing the Focus program — a substance abuse program offered through the Department of Corrections — or its equivalent prior to being released from prison.
According to a release issued by Attorney General Gordon MacDonald, Flanagan also pleaded guilty to additional charges of selling a controlled drug, selling a substance represented to be a controlled drug, and possession of a controlled drug with intent to sell as part of her negotiated plea.
Flanagan was sentenced to concurrent 3 1/2- to 7-year sentences in state prison on each of the three charges.
According to the release, on October 4, 2016, Somersworth police responded to the Somersworth Public Library, where they found Gross unconscious. Emergency personnel were unable to revive him, and he was declared dead.
Investigators determined Flanagan had sold fentanyl to Gross minutes before his death, and arranged a drug buy between her and an undercover officer on October 6.
Flanagan was arrested later that same day for possession of fentanyl with the intent to sell. Police say further investigations produced evidence that Flanagan was involved in two other drug transactions on October 6, resulting in two additional counts of selling a controlled drug.